Xenon Pharmaceuticals Inc — Dividend History & Yield (NASDAQ:XENE) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Dividends per share —————— — Dividend yield % —————— — Payout ratio % —————— —

Nouvelles

L’action Xenon Pharmaceuticals atteint un sommet de 52 semaines à 46,68$

Xenon Pharmaceuticals stock hits 52-week high at $46.68

Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus

Les résultats de Xenon approchent alors que les investisseurs se préparent au catalyseur de Phase 3

Xenon earnings loom as investors brace for Phase 3 catalyst

Wolfe Research initie la couverture de Xenon Pharmaceuticals avec une note de surperformance

Wolfe Research initiates Xenon Pharmaceuticals stock coverage with outperform rating

Xenon Pharmaceuticals Stock Scores RS Rating Upgrade

Stifel relève l’objectif de cours de Xenon Pharmaceuticals à 66$ sur le potentiel de XEN1101

Stifel raises Xenon Pharmaceuticals stock price target to $66 on XEN1101 potential

Biohaven stock rating upgraded by RBC Capital on promising CNS data

Xenon Pharmaceuticals Inc. (XENE) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:XENE) 2026-01-12